Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure

Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure

Conditions: Chronic Heart Failure
Interventions: Biological: MTP-101-C encapsulated Microbiota; Drug: Vancomycin; Drug: Neomycin
Sponsors: Melana Yuzefpolskaya, MD
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 25, 2026Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments